Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-54.50	76.28	167.66
Graham Fair Price	147.91	1816.30	732.64
PEG	-95.52	< 0.005	0.19
Price/Book	-3.53	0.84	0.87
Price/Cash Flow	-74.94	-2.19	8.72
Prices/Earnings	85.84	-4.70	-33.17
Price/Sales	22.99	1.13	0.92
Price/FCF	-74.94	-2.19	8.72
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	28.95	0.03	0.03
Operating Margin	532.65	-0.02	< 0.005
ROA	-592.11	-0.02	< 0.005
ROE	< 0.005	-0.04	-581.31
ROIC	< 0.005	-0.02	1999.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.23	0.10	140.04
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.85	-5.71	-568.41
EPS QOQ	-1.73	-5.47	-216.12
FCF QOQ	1.87	-4.66	149.10
Revenue QOQ	0.12	-0.26	108.33
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	37.20	46.54	25.13
Days Sales Outstanding (DSO)	115.81	157.51	36.01
Inventory Turnover	2.42	1.93	-20.09
Debt/Capitalization	0.44	0.50	13.57
Quick Ratio	1.05	1.18	13.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1908.15	1812.33	-5.02
Cash	545.65	156.31	-71.35
Capex	-1.47	-0.58	60.46
Free Cash Flow	190.25	-695.52	265.58
Revenue	1802.68	1342.88	-25.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.33	1.55	16.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	64.16	41.19	-35.79
Naive Interpretation	Member

06 - Financial Health · Weak

Rating